Linker Capital Management’s AbbVie ABBV Stock Holding History

Linker Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$763K	Hold	5,663	–	–	0.78%	22
2023 Q1	$903K	Hold	5,663	–	–	0.99%	21
2022 Q4	$915K	Hold	5,663	–	–	1.05%	21
2022 Q3	$760K	Hold	5,663	–	–	0.94%	21
2022 Q2	$867K	Hold	5,663	–	–	1.08%	19
2022 Q1	$918K	Hold	5,663	–	–	0.91%	21
2021 Q4	$767K	Buy	+5,663	New	+$669K	0.74%	26

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Linker Capital Management's ABBV Position: Q2 2023 in Review

Linker Capital Management held its AbbVie (ABBV) position steady in Q2 2023 at 5,663 shares worth $763K. The position accounts for 0.78% of the portfolio, ranked #22.

Linker Capital Management first reported a position in ABBV in Q4 2021 and has held it in 7 quarters since. The position peaked at $918K in Q1 2022. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Linker Capital Management held 5,663 shares of AbbVie worth $763K as of Q2 2023.
Linker Capital Management left its AbbVie share count unchanged in Q2 2023.
AbbVie made up 0.78% of Linker Capital Management's portfolio in Q2 2023, its #22 holding.
Linker Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 7 quarters since.
Linker Capital Management's AbbVie position peaked at $918K in Q1 2022.
3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Linker Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.